Jon Njardarson
13Patents
3h-index
24Co-inventors
56Inventor score
Filing activity: Mar 26, 2004 → Sep 9, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7943800B2 | Migrastatin analogs and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US8540965B2 | Single wall nanotube constructs and uses therefor | Chemistry; Metallurgy | 4 | Active |
| US8957056B2 | Migrastatin analogs in the treatment of cancer | Human Necessities | 3 | Active |
| US8202911B2 | Migrastatin analog compositions and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9629927B2 | Single wall nanotube constructs and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US8324284B2 | Migrastatin analogs and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US8835693B2 | Migrastatin analogs and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US11564988B2 | Single wall nanotube constructs and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10406236B2 | Single wall nanotube constructs and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10358438B2 | [3+2] annulation to produce 5-membered heterocyclic compounds | Chemistry; Metallurgy | 0 | Active |
| US8404872B2 | Production of 2,5-dihydrofurans and analogous compounds | Chemistry; Metallurgy | 0 | Active |
| US10370385B2 | Tricyclic mosquitocides and methods of making and using thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11147795B2 | Neuroprotective compounds and methods of use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.